- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03601663
Exploring the Effect of an Intervention on Women's Physical Activity Behaviour
23 de março de 2020 atualizado por: Jennifer Brunet, University of Ottawa
Exploring the Effect of an eHealth Intervention on Women's Physical Activity Behaviour
Physical activity has been shown to reduce the risk of chronic diseases and promote physical and mental health and wellbeing, yet few women are active enough to see these benefits.
Wearable activity trackers show promise for helping people increase their physical activity levels by supporting self-monitoring.
However, few researchers have examined how providing people with these devices impacts physical activity levels, or motivation for physical activity which is a significant and robust predictor of physical activity.
Based on previous research, it is possible that women's physical activity levels would be more likely to increase if they received an autonomy-supportive intervention to enhance motivation in addition to a wearable activity tracker.
A pilot, three-armed randomized controlled trial was developed to test this hypothesis and to assess if changes in perceived autonomy-support, basic psychological need satisfaction/thwarting, motivational regulations, wellbeing indicators are associated with changes in physical activity over time.
Visão geral do estudo
Status
Concluído
Condições
Tipo de estudo
Intervencional
Inscrição (Real)
49
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Ontario
-
Ottawa, Ontario, Canadá, K1N6N5
- University of Ottawa
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
18 anos a 65 anos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Fêmea
Descrição
All participants will need to meet the following inclusion criteria to participate in the intervention:
- Are a woman between the ages of 18 and 65 years
- Can understand, read, and speak in English
- Are able to safely engage in physical activity
- Are not currently pregnant or lactating
- Currently participating in less than 150 minutes of moderate or vigorous intensity physical activity and less than two strength training sessions per week
- Are overweight or obese (i.e., have a body mass index greater than 25kg/m2)
- Have access to the Internet and an email account
- Have not used a wearable activity tracker within the past year (e.g., Fitbit, Apple Watch, Garmin, Polar)
- Live within 50km of the University of Ottawa
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Group 1
Participants in the main experimental group will receive a copy of the Canadian Physical Activity Guidelines that provide basic information about and recommendations for physical activity, a wearable activity tracker to support self-monitoring, and autonomy-support delivered through weekly emails to help enhance motivation for physical activity.
|
Participants will receive a copy of the Canadian Physical Activity Guidelines.
Participants will receive a wearable activity tracker (Polar A300).
Participants will receive eight autonomy-supportive weekly emails containing information and activities to help them set goals and make changes to become physically active.
|
|
Comparador Ativo: Group 2
Participants in this comparison group will receive a copy of the Canadian Physical Activity Guidelines that provide basic information about and recommendations for physical activity, and a wearable activity tracker to support self-monitoring.
They will not receive any specific support to enhance motivation for physical activity.
|
Participants will receive a copy of the Canadian Physical Activity Guidelines.
Participants will receive a wearable activity tracker (Polar A300).
|
|
Comparador Ativo: Group 3
Participants in this information-only comparison group will receive a copy of the Canadian Physical Activity Guidelines that provide basic information about and recommendations for physical activity.
|
Participants will receive a copy of the Canadian Physical Activity Guidelines.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Physical activity behaviour: International Physical Activity Questionnaire Short Form (IPAQ-S)
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
Change in self-reported physical activity (over the past 7 days) from baseline to post-intervention, and from post-intervention to follow-up.
|
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
|
Physical activity behaviour: Custom strength and resistance training questionnaire
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
Change in strength and resistance training habits from baseline to post-intervention, and from post-intervention to follow-up.
|
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Physical activity behaviour: Direct measure
Prazo: Duration of intervention phase (8 weeks).
|
Change in weekly directly measured levels of physical activity as measured by accelerometers (Polar A300), which will be worn by participants assigned to Group 1 and Group 2 during waking hours for the duration of the intervention.
|
Duration of intervention phase (8 weeks).
|
|
Perceived autonomy support: Perceived Autonomy Support Scale for Exercise Settings (PASSES; Hagger et al., 2007)
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
Change in perceived autonomy support for physical activity from baseline to post-intervention, and from post-intervention to follow-up.
|
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
|
Basic psychological need satisfaction: Psychological Need Satisfaction in Exercise Scale (PNSE; Wilson, Rogers, Rodgers, & Wild, 2006)
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
Change in basic psychological need satisfaction for physical activity from baseline to post-intervention, and from post-intervention to follow-up.
|
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
|
Motivational regulations: Behavioral Regulation in Exercise Questionnaire (BREQ-2R; Markland & Tobin, 2004; Wilson, Rodgers, Loitz, & Scime, 2006)
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
Change in motivational regulations for physical activity from baseline to post-intervention, and from post-intervention to follow-up.
|
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
|
Basic psychological need thwarting: Psychological Need Thwarting Scale (PNTS; Bartholomew, Ntoumanis, Ryan, & Thøgersen-Ntoumani, 2011)
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
Change in basic psychological need thwarting activity from baseline to post-intervention, and from post-intervention to follow-up.
|
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
|
Positive and Negative Affect Schedule (I-PANAS-SF; Thompson, 2016; Watson, Clark, & Tellegen, 1988).
Prazo: : Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
Change in affect from baseline to post-intervention, and from post-intervention to follow-up.
|
: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
|
Vitality: Subjective Vitality Scale (Ryan & Frederick, 1997).
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
Change in vitality affect from baseline to post-intervention, and from post-intervention to follow-up.
|
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
|
Depression: Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer, & Williams, 2001).
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
Change in depressive symptoms from baseline to post-intervention, and from post-intervention to follow-up.
|
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
|
|
Wearable activity tracker usage: Multiple choice questions
Prazo: Post-intervention (week 9).
|
Frequency of wearable activity tracker usage in general during the intervention phase for participants randomized to Group 1 or Group 2.
|
Post-intervention (week 9).
|
|
Recruitment rates
Prazo: Duration of recruitment and intervention phases (9 weeks).
|
The number of eligible participants who enrol in the study out of the number assessed for eligibility.
|
Duration of recruitment and intervention phases (9 weeks).
|
|
Retention rates
Prazo: Duration of recruitment and intervention phases (9 weeks).
|
The number of participants completing all scheduled assessments.
|
Duration of recruitment and intervention phases (9 weeks).
|
|
Acceptability: Open ended questions
Prazo: Duration of recruitment and intervention phases (9 weeks).
|
For participants randomized to Group 1, what participants liked, disliked, and would change about the intervention.
|
Duration of recruitment and intervention phases (9 weeks).
|
|
Body mass
Prazo: Baseline (week 0) and post-intervention (week 9).
|
Change in body mass measured from baseline to post-intervention as determined using a scale (Tanita BWB 800S).
|
Baseline (week 0) and post-intervention (week 9).
|
|
Body composition
Prazo: Baseline (week 0) and post-intervention (week 9).
|
Change in body composition from baseline to post-intervention as determined by a scale (Tanita BWB 800S) that uses bioelectrical impedance to assess body composition.
|
Baseline (week 0) and post-intervention (week 9).
|
|
Waist circumference
Prazo: Baseline (week 0) and post-intervention (week 9).
|
Change in waist circumference from baseline to post-intervention as measured using a measuring tape.
|
Baseline (week 0) and post-intervention (week 9).
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Sociodemographic questionnaire
Prazo: Baseline (week 0).
|
Sociodemographic and health information will be collected at baseline to describe the sample.
Measures include age, marital status, race, level of education, employment status, household income, number and age of children, self-rated health, medical conditions, menstrual status, smoking history, and weight-related goals.
|
Baseline (week 0).
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Publicações e links úteis
A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.
Publicações Gerais
- Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063.
- Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
- Bartholomew KJ, Ntoumanis N, Ryan RM, Thogersen-Ntoumani C. Psychological need thwarting in the sport context: assessing the darker side of athletic experience. J Sport Exerc Psychol. 2011 Feb;33(1):75-102. doi: 10.1123/jsep.33.1.75.
- Hagger, M. S., Chatzisarantis, N. L., Hein, V., Pihu, M., Soós, I., & Karsai, I. (2007). The perceived autonomy support scale for exercise settings (PASSES): Development, validity, and cross-cultural invariance in young people. Psychology of Sport and Exercise, 8(5), 632-653. doi:10.1016/j.psychsport.2006.09.001
- Markland, D., & Tobin, V. (2004). A modification to the behavioural regulation in exercise questionnaire to include an assessment of amotivation. Journal of Sport & Exercise Psychology, 26, 191-196.
- Ryan RM, Frederick C. On energy, personality, and health: subjective vitality as a dynamic reflection of well-being. J Pers. 1997 Sep;65(3):529-65. doi: 10.1111/j.1467-6494.1997.tb00326.x.
- Thompson, E. R. (2016). Development and validation of an internationally reliable short-form of the Positive and Negative Affect Schedule (PANAS). Journal of Cross-Cultural Psychology, 38(2), 227-242. doi:10.1177/0022022106297301
- Wilson, P. M., Rodgers, W. M., Loitz, C., & Scime, G. (2006). "It's who I am… really!" The importance of integrated regulation in exercise contexts. Journal of Applied Biobehavioural Research, 11(2), 79-104.
- Wilson, P. M., Rogers, T., Rodgers, W. M., & Wild, C. (2006). The psychological need satisfaction in exercise scale. Journal of Sport & Exercise Psychology, 28, 231-251.
- Black M, Brunet J. A Wearable Activity Tracker Intervention With and Without Weekly Behavioral Support Emails to Promote Physical Activity Among Women Who Are Overweight or Obese: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2021 Dec 16;9(12):e28128. doi: 10.2196/28128.
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
1 de setembro de 2018
Conclusão Primária (Real)
22 de abril de 2019
Conclusão do estudo (Real)
30 de agosto de 2019
Datas de inscrição no estudo
Enviado pela primeira vez
4 de julho de 2018
Enviado pela primeira vez que atendeu aos critérios de CQ
17 de julho de 2018
Primeira postagem (Real)
26 de julho de 2018
Atualizações de registro de estudo
Última Atualização Postada (Real)
24 de março de 2020
Última atualização enviada que atendeu aos critérios de controle de qualidade
23 de março de 2020
Última verificação
1 de março de 2020
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- eHealth_Women_PA
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Não
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .